The Investigator Site File (ISF) is the collection of essential documents maintained at the investigational site, supporting the conduct and documentation of a clinical trial. It serves as the counterpart to the sponsor’s documents in the Trial Master File and must be maintained in a way that the investigator’s role, GCP compliance, and the protection of participants are verifiable. <\/p>\n
ICH E6(R3) describes essential documents as evidence that allows for the assessment of compliant study conduct and the reliability of results. The repository maintained by the investigator or institution can be referred to as the Investigator Site File. It contains or references the documents that the investigational site requires and must retain for its tasks. Depending on the study, these include, for example, approved protocols, informed consent documents, ethics committee and regulatory authority correspondence, delegation and training records, safety information, investigational product documentation, and site-specific documents. <\/p>\n
An ISF is not necessarily a paper folder. The requirements also apply to electronic repositories, portals, and hybrid storage. Crucial aspects are clear identification, version control where applicable, searchability, and retrievability. Documents must be complete, legible, and directly accessible to authorities, monitors, and auditors upon request; changes must remain traceable. The investigator or institution retains responsibility for the essential documents they generate and store. <\/p>\n
The sponsor’s Trial Master File and the Investigator Site File are not identical duplicate repositories. ICH E6(R3) provides for repositories at the sponsor and at the investigator or institution for their respective documents. Some documents are only held by one party, such as confidential participant information at the investigational site or analyses exclusively related to the sponsor at the sponsor’s end. Other documents must be accessible to or retained by both parties because they concern the joint conduct of the study. <\/p>\n
This division of labor requires regulated access and retention agreements, especially when tasks are delegated to service providers. At the end of the study, each party should retain its essential documents. The existing entry on trial-master-file describes the sponsor’s perspective; essential-documents addresses the category of documents. The Investigator Site File explains the practical site-specific context at the center and should therefore not be understood as a mere copy of the TMF. <\/p>\n
In practice, the Investigator Site File is often the first thing consulted during a monitoring visit or inspection because it makes the on-site conduct visible. This does not mean that it alone proves the entire study. Authorities and auditors can also review source documents, hospital records, electronic systems, and sponsor-side documents. However, the ISF creates the organized link between approved planning, personnel qualification, site procedures, and the required evidence. <\/p>\n
An Investigator Site File is neither a patient archive nor a repository for arbitrary copies. It should be clearly defined which documents are in the ISF, which are referenced via a controlled repository, and where originals are located. Particularly relevant are up-to-dateness after changes, access in case of personnel changes, protection of confidential information, and documented archiving. The EudraLex recommendation requires an organized filing system that facilitates study management, audit, and inspection. <\/p>\n
A current table of contents and a reference to controlled electronic repositories help to verify completeness without unnecessary multiple copies. When the investigator or study coordinator changes, access should be orderly transferred, and the whereabouts of the documents documented. <\/p>\n
An incomplete or disorganized ISF complicates monitoring and can prevent the reconstruction of study conduct. Common problems include outdated document versions, untracked training records, missing delegation documents, unclear separation from source documents, or unregulated access to sponsor portals. The investigational site therefore needs a practical folder structure and clear responsibilities so that documents are not only gathered shortly before a visit. <\/p>\n
Full-service CROs like Mediconomics support the establishment and maintenance of an ISF structure, the selection and provision of current site documents, monitoring control, and preparation for audits and inspections. They can coordinate documentation lists, training records, delegation records, and investigational product documents with the Trial Master File, track open items, and coordinate the archiving handover at the end of the study. <\/p>\n
Is the Investigator Site File always a paper folder?<\/strong><\/p>\n No. It can be maintained electronically, on paper, or in a hybrid format. Regardless of the medium, the documents must be identifiable, complete, legible, retrievable, and accessible when needed. <\/p>\n Who is responsible for the content of the Investigator Site File?<\/strong><\/p>\n The investigator or institution is responsible for their own essential documents. The sponsor and investigational site must also regulate access and retention issues for jointly relevant documents. <\/p>\n Is the Investigator Site File the same as the Trial Master File?<\/strong><\/p>\n No. Both serve to document essential documents, but they are maintained for the respective areas of responsibility of the investigational site and the sponsor and do not necessarily contain the same originals. <\/p>\n The Investigator Site File (ISF) is the collection of essential documents maintained at the investigational site, supporting the conduct and documentation of a clinical trial. It serves as the counterpart to the sponsor’s documents in the Trial Master File and must be maintained in a way that the investigator’s role, GCP compliance, and the protection […]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"glossary-cat":[21],"class_list":["post-7735","glossary","type-glossary","status-publish","hentry","glossary-cat-clinical-operations-gcp"],"acf":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/7735","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":0,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/7735\/revisions"}],"wp:attachment":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/media?parent=7735"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary-cat?post=7735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Regulatory References<\/h2>\n
\n